Al Sandrock (Biogen via Youtube)

'I bleed Bio­gen': Just months af­ter the big biotech was slammed fol­low­ing the con­tro­ver­sial OK of ad­u­canum­ab, R&D chief Al San­drock makes an abrupt ex­it

Two years af­ter Al San­drock jumped from CMO to the top post in R&D — and just months af­ter the hy­per-con­tro­ver­sial ap­proval of the ex­per­i­men­tal Alzheimer’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.